| Date Filed | Type | Description |
| 01/21/2020 |
SC 13G/A
| NB Public Equity K/S reports a 9% stake in Novelion Therapeutics Inc. |
| 12/17/2018 |
SC 13G/A
| NB Public Equity K/S reports a 9% stake in Novelion Therapeutics Inc. |
| 11/19/2018 |
SC 13G
| NB Public Equity K/S reports a 9% stake in Novelion Therapeutics Inc. |
| 05/04/2018 |
SC 13G
| NB Public Equity K/S reports a 9% stake in Alder BioPharmaceuticals, Inc. |
| 01/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/22/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/15/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/22/2012 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 05/18/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2011 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on QLT INC/BC|
Txns:
| Sold 200,000 shares
@ $7.0843, valued at
$1.4M
|
|
| 02/08/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/03/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 09/16/2010 |
SC 13G/A
| NB Public Equity K/S reports a 9% stake in SuperGen, Inc. |
| 05/13/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 04/28/2010 |
SC 13D/A
| NB Public Equity K/S reports a 10% stake in SuperGen, Inc. |
| 04/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2010 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on QLT INC/BC |
| 03/16/2010 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on QLT INC/BC|
Txns:
| Bought 3,300 shares
@ $4.86, valued at
$16k
Bought 2,031 shares
@ $4.87, valued at
$9.9k
Bought 8,003 shares
@ $4.88, valued at
$39.1k
Bought 2,900 shares
@ $4.89, valued at
$14.2k
Bought 2,100 shares
@ $4.9, valued at
$10.3k
Bought 4,100 shares
@ $4.94, valued at
$20.3k
Bought 52,238 shares
@ $4.95, valued at
$258.6k
Bought 50,575 shares
@ $4.96, valued at
$250.9k
Bought 26,921 shares
@ $4.97, valued at
$133.8k
Bought 100 shares
@ $4.98, valued at
$498
Bought 4,100 shares
@ $4.92, valued at
$20.2k
|
|
| 03/15/2010 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on QLT INC/BC|
Txns:
| Bought 100 shares
@ $4.82, valued at
$482
Bought 25,621 shares
@ $4.83, valued at
$123.7k
Bought 1,900 shares
@ $4.84, valued at
$9.2k
Bought 4,766 shares
@ $4.85, valued at
$23.1k
Bought 200 shares
@ $4.8525, valued at
$970.5
Bought 500 shares
@ $4.855, valued at
$2.4k
Bought 21,096 shares
@ $4.86, valued at
$102.5k
Bought 100 shares
@ $4.865, valued at
$486.5
Bought 100 shares
@ $4.8698, valued at
$487
Bought 28,520 shares
@ $4.87, valued at
$138.9k
Bought 1,000 shares
@ $4.875, valued at
$4.9k
|
|
| 03/15/2010 |
SC 13D
| NB Public Equity K/S reports a 11.1% stake in SuperGen, Inc. |
| 03/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2010 |
SC 13G/A
| NB Public Equity K/S reports a 9% stake in Facet Biotech Corporation |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2010 |
SC 13G/A
| NB Public Equity K/S reports a 9% stake in SuperGen, Inc. |
| 02/16/2010 |
SC 13G/A
| NB Public Equity K/S reports a 13.3% stake in QLT Inc. |
| 10/26/2009 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on SUPERGEN INC |
| 10/23/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/21/2009 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on QLT INC/BC |
| 10/13/2009 |
SC 13G
| NB Public Equity K/S reports a 9% stake in Transcept Pharmaceuticals, Inc. |
| 09/25/2009 |
SC 13G
| NB Public Equity K/S reports a 9% stake in Facet Biotech Corporation |
| 09/16/2009 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on SUPERGEN INC |
| 09/09/2009 |
4
| NB Public Equity K/S (10% Owner) has filed a Form 4 on SUPERGEN INC |
|